Literature DB >> 24998420

Mechanism and inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.

Andrew S Murkin1, Kathryn A Manning2, Svetlana A Kholodar2.   

Abstract

The non-mevalonate or 2-C-methyl-d-erythritol-4-phosphate (MEP) pathway is responsible for generating isoprenoid precursors in plants, protozoa, and bacteria. Because this pathway is absent in humans, its enzymes represent potential targets for the development of herbicides and antibiotics. 1-Deoxy-d-xylulose (DXP) reductoisomerase (DXR) is a particularly attractive target that catalyzes the pathway's first committed step: the sequential isomerization and NADPH-dependent reduction of DXP to MEP. This article provides a comprehensive review of the mechanistic and structural investigations on DXR, including its discovery and validation as a drug target, elucidation of its chemical and kinetic mechanisms, characterization of inhibition by the natural antibiotic fosmidomycin, and identification of structural features that provide the molecular basis for inhibition of and catalysis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  1-Deoxy-d-xylulose 5-phosphate (DXP); DXR; Enzyme mechanism; Fosmidomycin; Kinetic mechanism; Malaria; Reductoisomerase; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24998420     DOI: 10.1016/j.bioorg.2014.06.001

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  8 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Conformational dynamics of 1-deoxy-d-xylulose 5-phosphate synthase on ligand binding revealed by H/D exchange MS.

Authors:  Jieyu Zhou; Luying Yang; Alicia DeColli; Caren Freel Meyers; Natalia S Nemeria; Frank Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

3.  Toward a structome of Acinetobacter baumannii drug targets.

Authors:  Logan M Tillery; Kayleigh F Barrett; David M Dranow; Justin Craig; Roger Shek; Ian Chun; Lynn K Barrett; Isabelle Q Phan; Sandhya Subramanian; Jan Abendroth; Donald D Lorimer; Thomas E Edwards; Wesley C Van Voorhis
Journal:  Protein Sci       Date:  2020-01-20       Impact factor: 6.725

4.  Acyloxybenzyl and Alkoxyalkyl Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents.

Authors:  Charlotte Courtens; Martijn Risseeuw; Guy Caljon; Paul Cos; Serge Van Calenbergh
Journal:  ACS Med Chem Lett       Date:  2018-09-11       Impact factor: 4.345

5.  In silico characterization and differential expression analysis of 1-deoxy-d-xylulose-5-phosphate reductoisomerase (DXR) of Centella asiatica.

Authors:  Richa Sharma; Kamalakshi Devi; Mahendra K Modi; Priyabrata Sen
Journal:  3 Biotech       Date:  2021-03-22       Impact factor: 2.406

Review 6.  Cryptic binding sites on proteins: definition, detection, and druggability.

Authors:  Sandor Vajda; Dmitri Beglov; Amanda E Wakefield; Megan Egbert; Adrian Whitty
Journal:  Curr Opin Chem Biol       Date:  2018-05-23       Impact factor: 8.822

7.  The role of phosphate in a multistep enzymatic reaction: reactions of the substrate and intermediate in pieces.

Authors:  Svetlana A Kholodar; C Leigh Allen; Andrew M Gulick; Andrew S Murkin
Journal:  J Am Chem Soc       Date:  2015-02-10       Impact factor: 15.419

8.  Photosynthetic conversion of CO2 to farnesyl diphosphate-derived phytochemicals (amorpha-4,11-diene and squalene) by engineered cyanobacteria.

Authors:  Sun Young Choi; Hyun Jeong Lee; Jaeyeon Choi; Jiye Kim; Sang Jun Sim; Youngsoon Um; Yunje Kim; Taek Soon Lee; Jay D Keasling; Han Min Woo
Journal:  Biotechnol Biofuels       Date:  2016-09-22       Impact factor: 6.040

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.